-- Arena shares down after drug study results
-- 
-- Fri Sep 18, 2009 8:16am EDT
-- http://www.reuters.com/article/2009/09/18/us-arenapharma-btb-sb-idUSTRE58H2HQ20090918

 

 NEW YORK  (Reuters) - Shares of Arena Pharmaceuticals Inc ( ARNA.O ) fell 17.7 percent to $4.04 in premarket trading on Friday, after it said that its experimental obesity drug met the goals of a second late-stage study but fell short of a U.S. Food and Drug Administration guideline. 

 (Reporting by  Ryan Vlastelica ; Editing by Theodore d'Afflisio)